 Robin Shandas
Concepts (370)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Cardiovascular | 32 | 2016 | 172 | 3.830 |
Why?
| | Pulmonary Artery | 26 | 2016 | 1031 | 3.430 |
Why?
| | Hypertension, Pulmonary | 24 | 2017 | 1749 | 2.530 |
Why?
| | Ultrasonography | 15 | 2017 | 641 | 2.510 |
Why?
| | Rheology | 9 | 2018 | 88 | 2.070 |
Why?
| | Blood Flow Velocity | 24 | 2018 | 324 | 1.960 |
Why?
| | Microbubbles | 12 | 2013 | 40 | 1.940 |
Why?
| | Pulmonary Circulation | 10 | 2017 | 407 | 1.890 |
Why?
| | Image Interpretation, Computer-Assisted | 9 | 2016 | 220 | 1.500 |
Why?
| | Vascular Resistance | 8 | 2017 | 338 | 1.350 |
Why?
| | Hemorheology | 9 | 2005 | 20 | 1.130 |
Why?
| | Carotid Arteries | 5 | 2017 | 183 | 1.100 |
Why?
| | Contrast Media | 8 | 2017 | 362 | 1.040 |
Why?
| | Ultrasonography, Doppler | 4 | 2018 | 105 | 0.950 |
Why?
| | Hemodynamics | 9 | 2017 | 968 | 0.940 |
Why?
| | Blood Pressure | 14 | 2016 | 1537 | 0.920 |
Why?
| | Algorithms | 8 | 2016 | 1490 | 0.910 |
Why?
| | Surgical Mesh | 2 | 2013 | 42 | 0.870 |
Why?
| | Fontan Procedure | 7 | 2009 | 156 | 0.850 |
Why?
| | Computer Simulation | 18 | 2018 | 881 | 0.820 |
Why?
| | Polymers | 7 | 2018 | 464 | 0.770 |
Why?
| | Materials Testing | 6 | 2019 | 356 | 0.770 |
Why?
| | Echocardiography, Doppler | 5 | 2006 | 90 | 0.760 |
Why?
| | Heart Ventricles | 5 | 2016 | 712 | 0.700 |
Why?
| | Arteries | 6 | 2013 | 250 | 0.690 |
Why?
| | Stress, Mechanical | 14 | 2018 | 440 | 0.670 |
Why?
| | Models, Biological | 7 | 2011 | 1646 | 0.670 |
Why?
| | Laparoscopy | 2 | 2013 | 400 | 0.660 |
Why?
| | Carotid Artery, Common | 1 | 2018 | 30 | 0.610 |
Why?
| | Image Enhancement | 3 | 2009 | 173 | 0.610 |
Why?
| | Image Processing, Computer-Assisted | 5 | 2017 | 691 | 0.590 |
Why?
| | Blood Pressure Determination | 3 | 2008 | 122 | 0.580 |
Why?
| | Models, Theoretical | 7 | 2013 | 519 | 0.580 |
Why?
| | Transducers | 2 | 2009 | 25 | 0.560 |
Why?
| | Patient-Specific Modeling | 1 | 2016 | 37 | 0.550 |
Why?
| | Heart Defects, Congenital | 5 | 2007 | 659 | 0.550 |
Why?
| | Imaging, Three-Dimensional | 5 | 2013 | 495 | 0.540 |
Why?
| | Compliance | 4 | 2011 | 44 | 0.520 |
Why?
| | Ultrasonics | 3 | 2013 | 48 | 0.510 |
Why?
| | Elasticity | 10 | 2015 | 194 | 0.480 |
Why?
| | Vascular Endothelial Growth Factor A | 5 | 2022 | 503 | 0.480 |
Why?
| | Elastic Modulus | 3 | 2013 | 118 | 0.460 |
Why?
| | Hernia, Ventral | 1 | 2013 | 18 | 0.450 |
Why?
| | Polyesters | 1 | 2013 | 65 | 0.440 |
Why?
| | Reproducibility of Results | 10 | 2018 | 2800 | 0.440 |
Why?
| | Ventricular Function, Right | 4 | 2017 | 251 | 0.440 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2015 | 222 | 0.430 |
Why?
| | Biocompatible Materials | 3 | 2013 | 378 | 0.430 |
Why?
| | Magnetic Resonance Imaging | 4 | 2017 | 3071 | 0.420 |
Why?
| | Vasodilator Agents | 2 | 2011 | 308 | 0.410 |
Why?
| | Heart-Assist Devices | 2 | 2009 | 486 | 0.400 |
Why?
| | Elastin | 2 | 2011 | 78 | 0.400 |
Why?
| | Equipment Failure Analysis | 5 | 2013 | 135 | 0.400 |
Why?
| | Cattle | 11 | 2017 | 935 | 0.390 |
Why?
| | Models, Anatomic | 3 | 2018 | 92 | 0.380 |
Why?
| | Heart Bypass, Right | 3 | 2006 | 15 | 0.380 |
Why?
| | Vascular Stiffness | 6 | 2017 | 411 | 0.380 |
Why?
| | MicroRNAs | 1 | 2017 | 607 | 0.380 |
Why?
| | Myocardial Perfusion Imaging | 1 | 2011 | 33 | 0.370 |
Why?
| | Ventricular Function, Left | 3 | 2004 | 467 | 0.370 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2010 | 6 | 0.360 |
Why?
| | Shear Strength | 5 | 2017 | 55 | 0.340 |
Why?
| | Uncertainty | 1 | 2010 | 97 | 0.340 |
Why?
| | Micro-Electrical-Mechanical Systems | 1 | 2009 | 5 | 0.340 |
Why?
| | Animals | 31 | 2022 | 32102 | 0.330 |
Why?
| | Numerical Analysis, Computer-Assisted | 4 | 2004 | 17 | 0.330 |
Why?
| | Child | 19 | 2018 | 18489 | 0.320 |
Why?
| | Miniaturization | 2 | 2009 | 24 | 0.310 |
Why?
| | Humans | 53 | 2018 | 115589 | 0.310 |
Why?
| | Aortic Valve | 2 | 2009 | 342 | 0.300 |
Why?
| | Laser-Doppler Flowmetry | 2 | 2004 | 32 | 0.290 |
Why?
| | Tissue Scaffolds | 3 | 2019 | 180 | 0.290 |
Why?
| | Phantoms, Imaging | 4 | 2014 | 134 | 0.290 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2017 | 239 | 0.290 |
Why?
| | Biomarkers | 1 | 2017 | 3467 | 0.290 |
Why?
| | Heart Septal Defects | 1 | 2006 | 10 | 0.280 |
Why?
| | Child, Preschool | 15 | 2017 | 9133 | 0.270 |
Why?
| | Gels | 2 | 2018 | 72 | 0.270 |
Why?
| | Lung | 4 | 2013 | 3672 | 0.270 |
Why?
| | Vasomotor System | 1 | 2006 | 38 | 0.270 |
Why?
| | Pulsatile Flow | 6 | 2012 | 54 | 0.270 |
Why?
| | Male | 24 | 2018 | 55949 | 0.270 |
Why?
| | Sensitivity and Specificity | 7 | 2016 | 1718 | 0.260 |
Why?
| | In Vitro Techniques | 6 | 2012 | 1044 | 0.260 |
Why?
| | Magnetic Resonance Imaging, Cine | 2 | 2017 | 160 | 0.260 |
Why?
| | Tissue Engineering | 3 | 2019 | 366 | 0.250 |
Why?
| | Hypoxia | 1 | 2011 | 937 | 0.250 |
Why?
| | Female | 23 | 2018 | 59913 | 0.250 |
Why?
| | Myocytes, Cardiac | 3 | 2019 | 457 | 0.250 |
Why?
| | Reference Values | 4 | 2018 | 744 | 0.250 |
Why?
| | Scattering, Radiation | 4 | 2006 | 91 | 0.240 |
Why?
| | Cardiovascular System | 2 | 2006 | 124 | 0.240 |
Why?
| | Linear Models | 3 | 2007 | 776 | 0.240 |
Why?
| | Rats, Sprague-Dawley | 6 | 2019 | 2262 | 0.240 |
Why?
| | Diagnosis, Computer-Assisted | 2 | 2005 | 64 | 0.230 |
Why?
| | Stroke Volume | 2 | 2017 | 509 | 0.230 |
Why?
| | Aorta | 2 | 2005 | 353 | 0.230 |
Why?
| | Connective Tissue | 1 | 2004 | 36 | 0.230 |
Why?
| | Rats | 7 | 2019 | 5034 | 0.230 |
Why?
| | Ventricular Function | 1 | 2004 | 57 | 0.230 |
Why?
| | Physical Stimulation | 1 | 2004 | 78 | 0.230 |
Why?
| | Energy Transfer | 1 | 2004 | 47 | 0.220 |
Why?
| | Crystallization | 1 | 2004 | 138 | 0.220 |
Why?
| | Animals, Newborn | 5 | 2016 | 780 | 0.220 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2004 | 106 | 0.210 |
Why?
| | Nanotechnology | 1 | 2004 | 115 | 0.210 |
Why?
| | Echocardiography | 2 | 2005 | 558 | 0.210 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2006 | 366 | 0.210 |
Why?
| | Hydrogels | 3 | 2022 | 581 | 0.210 |
Why?
| | Biomechanical Phenomena | 4 | 2013 | 677 | 0.200 |
Why?
| | Aortic Coarctation | 1 | 2003 | 67 | 0.200 |
Why?
| | Coronary Angiography | 1 | 2004 | 307 | 0.190 |
Why?
| | Neovascularization, Physiologic | 2 | 2020 | 174 | 0.190 |
Why?
| | Acrylamides | 2 | 2018 | 43 | 0.180 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2017 | 420 | 0.180 |
Why?
| | Case-Control Studies | 5 | 2017 | 3022 | 0.180 |
Why?
| | Adolescent | 12 | 2017 | 17890 | 0.180 |
Why?
| | Cardiac Catheterization | 4 | 2015 | 536 | 0.180 |
Why?
| | Delayed-Action Preparations | 2 | 2018 | 159 | 0.180 |
Why?
| | Hypertension | 1 | 2008 | 1064 | 0.180 |
Why?
| | Regional Blood Flow | 6 | 2013 | 414 | 0.180 |
Why?
| | Infant | 8 | 2015 | 7979 | 0.170 |
Why?
| | Equipment Design | 4 | 2014 | 517 | 0.170 |
Why?
| | Vena Cava, Inferior | 3 | 2006 | 55 | 0.170 |
Why?
| | Temperature | 3 | 2014 | 587 | 0.170 |
Why?
| | Models, Statistical | 3 | 2015 | 606 | 0.160 |
Why?
| | Biomimetic Materials | 2 | 2017 | 64 | 0.160 |
Why?
| | Particle Size | 4 | 2013 | 319 | 0.160 |
Why?
| | Ultrasonography, Doppler, Color | 2 | 2010 | 33 | 0.160 |
Why?
| | Echocardiography, Three-Dimensional | 1 | 1999 | 48 | 0.160 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2018 | 22 | 0.160 |
Why?
| | Gold | 1 | 2019 | 107 | 0.150 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 75 | 0.150 |
Why?
| | Myocardial Infarction | 2 | 2022 | 931 | 0.150 |
Why?
| | Heart Valve Diseases | 1 | 1999 | 116 | 0.150 |
Why?
| | Sulfones | 1 | 2018 | 98 | 0.150 |
Why?
| | Pulmonary Wedge Pressure | 2 | 2009 | 63 | 0.150 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 43 | 0.140 |
Why?
| | Computer-Aided Design | 2 | 2009 | 40 | 0.140 |
Why?
| | Finite Element Analysis | 3 | 2007 | 69 | 0.140 |
Why?
| | Bronchoscopy | 1 | 2018 | 245 | 0.140 |
Why?
| | Cardiac Output | 1 | 2016 | 143 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2011 | 3580 | 0.130 |
Why?
| | Laminin | 1 | 2016 | 69 | 0.130 |
Why?
| | Biomimetics | 1 | 2016 | 36 | 0.130 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 6 | 0.130 |
Why?
| | Endothelial Cells | 2 | 2012 | 695 | 0.130 |
Why?
| | Embryonic Stem Cells | 1 | 2016 | 105 | 0.130 |
Why?
| | Drug Carriers | 2 | 2013 | 113 | 0.130 |
Why?
| | Acoustics | 2 | 2006 | 55 | 0.120 |
Why?
| | Arterial Pressure | 1 | 2015 | 95 | 0.120 |
Why?
| | Pilot Projects | 2 | 2011 | 1377 | 0.120 |
Why?
| | Severity of Illness Index | 4 | 2017 | 2578 | 0.120 |
Why?
| | Fibroblasts | 1 | 2019 | 839 | 0.120 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 65 | 0.120 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2013 | 191 | 0.120 |
Why?
| | Magnetic Resonance Angiography | 1 | 2016 | 209 | 0.120 |
Why?
| | Bronchi | 1 | 2015 | 250 | 0.120 |
Why?
| | Lysine | 1 | 2016 | 245 | 0.120 |
Why?
| | Feasibility Studies | 4 | 2015 | 741 | 0.110 |
Why?
| | Myocardium | 1 | 2019 | 926 | 0.110 |
Why?
| | Airway Extubation | 1 | 2014 | 45 | 0.110 |
Why?
| | Stearic Acids | 1 | 2013 | 12 | 0.110 |
Why?
| | Polyethyleneimine | 1 | 2013 | 18 | 0.110 |
Why?
| | Cells, Cultured | 7 | 2017 | 3914 | 0.110 |
Why?
| | Portal Vein | 1 | 2014 | 81 | 0.110 |
Why?
| | Phonophoresis | 1 | 2013 | 1 | 0.110 |
Why?
| | Heparin | 1 | 2014 | 227 | 0.110 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2013 | 72 | 0.110 |
Why?
| | Silicon Dioxide | 1 | 2013 | 94 | 0.110 |
Why?
| | Vena Cava, Superior | 2 | 2003 | 20 | 0.110 |
Why?
| | Herniorrhaphy | 1 | 2013 | 50 | 0.110 |
Why?
| | Microspheres | 2 | 2006 | 122 | 0.110 |
Why?
| | Time Factors | 4 | 2015 | 6165 | 0.100 |
Why?
| | Tensile Strength | 1 | 2013 | 103 | 0.100 |
Why?
| | Collagen | 2 | 2012 | 415 | 0.100 |
Why?
| | Industry | 1 | 2013 | 65 | 0.100 |
Why?
| | Cell Separation | 1 | 2013 | 293 | 0.100 |
Why?
| | Intubation, Intratracheal | 1 | 2014 | 215 | 0.100 |
Why?
| | Tetraspanin 28 | 1 | 2012 | 4 | 0.100 |
Why?
| | Neural Stem Cells | 1 | 2013 | 115 | 0.100 |
Why?
| | Coronary Vessels | 2 | 2004 | 229 | 0.100 |
Why?
| | Paclitaxel | 1 | 2013 | 192 | 0.100 |
Why?
| | Structure-Activity Relationship | 2 | 2013 | 511 | 0.100 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2013 | 181 | 0.100 |
Why?
| | Sutures | 1 | 2012 | 60 | 0.100 |
Why?
| | Elastic Tissue | 1 | 2011 | 7 | 0.100 |
Why?
| | Fibrillar Collagens | 1 | 2011 | 12 | 0.100 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2012 | 58 | 0.100 |
Why?
| | Transfection | 1 | 2013 | 866 | 0.100 |
Why?
| | Predictive Value of Tests | 3 | 2015 | 1805 | 0.090 |
Why?
| | Diagnostic Imaging | 1 | 2014 | 296 | 0.090 |
Why?
| | Models, Animal | 1 | 2013 | 350 | 0.090 |
Why?
| | Angiogenesis Inhibitors | 1 | 2013 | 216 | 0.090 |
Why?
| | Oscillometry | 2 | 2013 | 33 | 0.090 |
Why?
| | Suture Techniques | 1 | 2012 | 130 | 0.090 |
Why?
| | Pressure | 3 | 2014 | 220 | 0.090 |
Why?
| | Swine | 1 | 2013 | 704 | 0.090 |
Why?
| | Arthroplasty | 1 | 2010 | 50 | 0.090 |
Why?
| | Intervertebral Disc Displacement | 1 | 2010 | 36 | 0.090 |
Why?
| | Equipment Failure | 1 | 2010 | 109 | 0.090 |
Why?
| | Species Specificity | 1 | 2011 | 552 | 0.090 |
Why?
| | Flow Cytometry | 1 | 2013 | 1083 | 0.090 |
Why?
| | Mice | 8 | 2022 | 15052 | 0.090 |
Why?
| | Cell Membrane | 1 | 2013 | 683 | 0.090 |
Why?
| | Lipids | 1 | 2013 | 588 | 0.090 |
Why?
| | Nanoparticles | 1 | 2013 | 316 | 0.090 |
Why?
| | Middle Aged | 4 | 2018 | 26998 | 0.090 |
Why?
| | Coculture Techniques | 3 | 2019 | 202 | 0.090 |
Why?
| | Central Venous Pressure | 1 | 2009 | 12 | 0.090 |
Why?
| | Viscosity | 1 | 2009 | 82 | 0.080 |
Why?
| | Electric Capacitance | 1 | 2009 | 7 | 0.080 |
Why?
| | Endothelial Growth Factors | 1 | 2009 | 50 | 0.080 |
Why?
| | Prosthesis Implantation | 1 | 2010 | 139 | 0.080 |
Why?
| | Prostheses and Implants | 1 | 2010 | 140 | 0.080 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2013 | 667 | 0.080 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2000 | 37 | 0.080 |
Why?
| | Internship and Residency | 1 | 2018 | 951 | 0.080 |
Why?
| | Vasoconstrictor Agents | 1 | 2009 | 113 | 0.080 |
Why?
| | Stress, Physiological | 1 | 2012 | 399 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 1 | 2008 | 37 | 0.080 |
Why?
| | Prosthesis Design | 2 | 2007 | 287 | 0.080 |
Why?
| | Atherosclerosis | 1 | 2012 | 341 | 0.080 |
Why?
| | Cell Adhesion Molecules | 1 | 2009 | 168 | 0.080 |
Why?
| | Logistic Models | 2 | 2015 | 1856 | 0.070 |
Why?
| | Reference Standards | 1 | 2008 | 161 | 0.070 |
Why?
| | Tunica Media | 1 | 2007 | 35 | 0.070 |
Why?
| | Electric Impedance | 1 | 2007 | 99 | 0.070 |
Why?
| | Tunica Intima | 1 | 2007 | 78 | 0.070 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2008 | 114 | 0.070 |
Why?
| | DNA | 1 | 2013 | 1356 | 0.070 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2007 | 137 | 0.070 |
Why?
| | Probability | 1 | 2007 | 294 | 0.070 |
Why?
| | Endothelium, Vascular | 2 | 2012 | 845 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2013 | 1700 | 0.070 |
Why?
| | Blood Vessel Prosthesis | 1 | 2007 | 113 | 0.070 |
Why?
| | Prospective Studies | 1 | 2017 | 6264 | 0.070 |
Why?
| | Nanotubes | 1 | 2006 | 41 | 0.060 |
Why?
| | Hemolysis | 1 | 2006 | 146 | 0.060 |
Why?
| | Protein Conformation | 1 | 2008 | 822 | 0.060 |
Why?
| | Venae Cavae | 1 | 2005 | 9 | 0.060 |
Why?
| | Aortic Valve Stenosis | 2 | 1999 | 253 | 0.060 |
Why?
| | Adaptation, Physiological | 1 | 2008 | 476 | 0.060 |
Why?
| | Radiography | 1 | 2007 | 826 | 0.060 |
Why?
| | Surgery, Computer-Assisted | 1 | 2005 | 63 | 0.060 |
Why?
| | Computing Methodologies | 1 | 2004 | 2 | 0.060 |
Why?
| | ROC Curve | 2 | 2015 | 451 | 0.060 |
Why?
| | Manufactured Materials | 1 | 2004 | 5 | 0.060 |
Why?
| | Research Design | 1 | 2010 | 946 | 0.060 |
Why?
| | Anatomy, Cross-Sectional | 1 | 2004 | 12 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1598 | 0.060 |
Why?
| | Rats, Long-Evans | 1 | 2004 | 100 | 0.060 |
Why?
| | Quality Control | 1 | 2004 | 147 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2392 | 0.060 |
Why?
| | Motion | 1 | 2004 | 94 | 0.050 |
Why?
| | Mitral Valve | 1 | 2004 | 84 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 1893 | 0.050 |
Why?
| | Dogs | 1 | 2004 | 341 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2013 | 1872 | 0.050 |
Why?
| | Heart | 1 | 2006 | 608 | 0.050 |
Why?
| | Ultrasonography, Interventional | 1 | 2002 | 125 | 0.050 |
Why?
| | Pediatrics | 2 | 2006 | 986 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2009 | 2574 | 0.050 |
Why?
| | Cytokines | 1 | 2009 | 1853 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2015 | 12608 | 0.050 |
Why?
| | Binomial Distribution | 1 | 2000 | 4 | 0.050 |
Why?
| | Risk Factors | 2 | 2015 | 8697 | 0.050 |
Why?
| | Interleukin-10 | 1 | 2022 | 299 | 0.040 |
Why?
| | Cell Survival | 2 | 2013 | 1024 | 0.040 |
Why?
| | Mechanotransduction, Cellular | 2 | 2012 | 96 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2020 | 82 | 0.040 |
Why?
| | Myosin Heavy Chains | 2 | 2012 | 169 | 0.040 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2020 | 90 | 0.040 |
Why?
| | Albumins | 1 | 1999 | 91 | 0.040 |
Why?
| | Actins | 2 | 2012 | 383 | 0.040 |
Why?
| | Cell Line | 2 | 2014 | 2651 | 0.040 |
Why?
| | Prognosis | 2 | 2017 | 3339 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2018 | 137 | 0.040 |
Why?
| | Formative Feedback | 1 | 2018 | 23 | 0.040 |
Why?
| | Mitral Valve Stenosis | 1 | 1998 | 19 | 0.040 |
Why?
| | Gelatin | 1 | 2017 | 36 | 0.040 |
Why?
| | Age Factors | 2 | 2015 | 2907 | 0.040 |
Why?
| | Young Adult | 3 | 2015 | 10470 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2015 | 177 | 0.030 |
Why?
| | Aging | 1 | 2005 | 1631 | 0.030 |
Why?
| | Demography | 1 | 2015 | 261 | 0.030 |
Why?
| | Sulfonic Acids | 1 | 2014 | 12 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 278 | 0.030 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2014 | 21 | 0.030 |
Why?
| | Phase Transition | 1 | 2014 | 26 | 0.030 |
Why?
| | Manikins | 1 | 2014 | 24 | 0.030 |
Why?
| | Constriction, Pathologic | 3 | 2000 | 210 | 0.030 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2014 | 76 | 0.030 |
Why?
| | Circular Dichroism | 1 | 2014 | 135 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2194 | 0.030 |
Why?
| | Static Electricity | 1 | 2014 | 117 | 0.030 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2014 | 194 | 0.030 |
Why?
| | Patient Positioning | 1 | 2014 | 43 | 0.030 |
Why?
| | Cardiography, Impedance | 1 | 2013 | 6 | 0.030 |
Why?
| | Adhesiveness | 1 | 2013 | 19 | 0.030 |
Why?
| | Luciferases, Firefly | 1 | 2013 | 3 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 316 | 0.030 |
Why?
| | Head | 1 | 2014 | 86 | 0.030 |
Why?
| | Airway Management | 1 | 2014 | 60 | 0.030 |
Why?
| | Adult | 3 | 2010 | 30719 | 0.030 |
Why?
| | Porosity | 1 | 2013 | 93 | 0.030 |
Why?
| | MCF-7 Cells | 1 | 2013 | 105 | 0.030 |
Why?
| | Trastuzumab | 1 | 2013 | 89 | 0.030 |
Why?
| | Sonication | 1 | 2013 | 10 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2013 | 180 | 0.030 |
Why?
| | Cell Death | 1 | 2014 | 326 | 0.030 |
Why?
| | Ramipril | 1 | 2012 | 4 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1650 | 0.030 |
Why?
| | Quantum Dots | 1 | 2013 | 35 | 0.030 |
Why?
| | Treatment Outcome | 4 | 2013 | 9159 | 0.030 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2012 | 53 | 0.030 |
Why?
| | Plasmids | 1 | 2013 | 345 | 0.030 |
Why?
| | Hypertrophy | 1 | 2012 | 110 | 0.030 |
Why?
| | Drug Compounding | 1 | 2013 | 89 | 0.030 |
Why?
| | Solubility | 1 | 2013 | 226 | 0.030 |
Why?
| | Methylphenazonium Methosulfate | 1 | 2012 | 1 | 0.030 |
Why?
| | Surface Properties | 1 | 2013 | 397 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2013 | 850 | 0.020 |
Why?
| | Hyaluronic Acid | 1 | 2013 | 190 | 0.020 |
Why?
| | Liposomes | 1 | 2013 | 149 | 0.020 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2012 | 156 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 912 | 0.020 |
Why?
| | Microcirculation | 1 | 2012 | 138 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 390 | 0.020 |
Why?
| | Vasodilation | 1 | 2013 | 412 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2013 | 704 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1642 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1168 | 0.020 |
Why?
| | Thromboxane B2 | 1 | 2009 | 27 | 0.020 |
Why?
| | Prostaglandins F | 1 | 2009 | 17 | 0.020 |
Why?
| | Software | 1 | 2013 | 541 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2499 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 1870 | 0.020 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 1 | 2009 | 25 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1153 | 0.020 |
Why?
| | E-Selectin | 1 | 2009 | 54 | 0.020 |
Why?
| | Sulfonamides | 1 | 2012 | 447 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 4773 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 105 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2013 | 576 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2009 | 185 | 0.020 |
Why?
| | Cadherins | 1 | 2009 | 175 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 167 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2011 | 439 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2009 | 340 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2009 | 400 | 0.020 |
Why?
| | Acrylates | 1 | 2007 | 47 | 0.020 |
Why?
| | Antigens, CD | 1 | 2009 | 442 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 1227 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 2751 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 820 | 0.020 |
Why?
| | Phosphorylation | 1 | 2009 | 1571 | 0.020 |
Why?
| | Disease Progression | 1 | 2012 | 2418 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2009 | 832 | 0.010 |
Why?
| | Gene Expression | 1 | 2009 | 1436 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2377 | 0.010 |
Why?
| | Stents | 1 | 2007 | 475 | 0.010 |
Why?
| | Regression Analysis | 1 | 2005 | 959 | 0.010 |
Why?
| | Monitoring, Intraoperative | 1 | 2002 | 39 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 2002 | 140 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1999 | 90 | 0.010 |
Why?
| | Veins | 1 | 1998 | 57 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 4944 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2002 | 2161 | 0.010 |
Why?
| | Aged | 1 | 2005 | 19250 | 0.000 |
Why?
|
|
Shandas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|